antibodies slc3a2 (Proteintech)
Structured Review
Antibodies Slc3a2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 132 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/slc3a2+antibody/CD98%2FSLC3A2+Antibody/10__1007_slash_s13402___026___01299___y-159-10-13
Average 96 stars, based on 132 article reviews
Images
Related Articles
Expressing:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Knockdown:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Western Blot:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Quantitative RT-PCR:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Over Expression:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Binding Assay:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Modification:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), ChIP-qPCR:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Mutagenesis:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Clone Assay:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Luciferase:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Plasmid Preparation:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Activity Assay:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Transfection:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Control:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Stable Transfection:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), CCK-8 Assay:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Colony Assay:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Transwell Assay:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Migration:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Injection:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Membrane:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Immunohistochemistry:Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis. Article Snippet: Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), Article Title: JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis Article Snippet: Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.Both DMED and RPMI-1640 were supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% penicillin/streptomycin.. The antibodies used in this study were listed as follows: JMJD6 antibody (Santa Cruz Biotechnology, Cat# sc-28348, 1:1000), METTL14 antibody (CST, Cat# 48699, 1:1000), |
